Portraza IV infusion 800mg, manufactured by Nippon Kayaku, contains necitumumab (genetical recombination). This injectable drug (YJ code: 4291448A1026) is supplied as 800mg in 50mL per bottle and is indicated for the treatment of metastatic squamous non-small cell lung cancer.
Portraza IV infusion 800mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).